[] [Advanced Semiconductor Engineering, Inc. Chapter One: General Principles Article 1. 日月光半導體製造股份有限公司 Article 2. (1) The manufacture, assembly, processing, test and export of various types of integrated circuitry; (2) The research, development, design and manufacture, assembly, processing, test and ]
[FORM 6-K VisionChina Media Inc. c/o Borrelli Walsh (Cayman) Limited G/F, Harbour Place 103 South Church Street Grand Cayman ☒ Form 20-F Bankruptcy or Receivership Section 99 of the Companies Law (2016 Revision) of the Cayman Islands which provides that: The Liquidators draw your attention to "When a]
[This Form 6-K consists of: HUANENG POWER INTERNATIONAL, INC. FILES 2016 ANNUAL REPORT ON FORM 20-F www.sec.gov The Company has posted the 2016 Annual Report on its website at www.hpi.com.cn. The 2016 Annual Report can also be accessed electronically at About the Company Huaneng Power International, ]
[UTStarcom Holdings Corp. Special Committee Retains Financial Advisor and Legal Counsel Hong Kong, April 19, 2017 About UTStarcom Holdings Corp. UTStarcom is a global telecom infrastructure provider dedicated to developing technology that will serve the rapidly growing demand for bandwidth from clo]
[Cleantech Solutions International Reports Full Year 2016 Results Wuxi, Jiangsu Province, China “This was a year of transition for Cleantech Solutions. With our forged rolled rings and related components and petroleum and chemical equipment segments continuing to perform poorly, we decided the best c]
[Table of Contents Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report. 278,282,366 Ordinary Shares. x Yes o No o Yes x No x Yes o No x Yes o No Large accelerated filer x Accelerated filer o No]
[FORM 20-F (Mark One) o OR x OR o OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . For the transition period from to NETEASE, INC. N/A Cayman Islands (Jurisdiction of incorporation or organization) Building No. 7, West Zone, Zhongguancun] [SHAREHOLDER VOTIN]
[INTRODUCTION 1 1 PART I 3 ITEM 1 IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2 OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3 KEY INFORMATION 3 ITEM 4 INFORMATION ON THE COMPANY 38 ITEM 4A UNRESOLVED STAFF COMMENTS 70 ITEM 5 OPERATING AND FINANCIAL REVIEW AND PROSPECTS 70 ITEM 6 D]
[Schedule 14A ☒ ☐ Check the appropriate box: ☐ ☐ ☒ ☐ ☐ Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): ☒ ☐ (1) Title of each class of securities to which transaction applies: _____________________________ (2) Aggregate number of s]
[EX-99.1 2 ex99-1.htm EX-99.1] []
